170 related articles for article (PubMed ID: 29124154)
1. Psoriasis pathogenesis - Pso p27 constitutes a compact structure forming large aggregates.
Lysvand H; Helland R; Hagen L; Slupphaug G; Iversen OJ
Biochem Biophys Rep; 2015 Jul; 2():132-136. PubMed ID: 29124154
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis pathogenesis - Pso p27 is generated from SCCA1 with chymase.
Lysvand H; Hagen L; Klubicka L; Slupphaug G; Iversen OJ
Biochim Biophys Acta; 2014 May; 1842(5):734-8. PubMed ID: 24560885
[TBL] [Abstract][Full Text] [Related]
3. Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases.
Iversen OJ; Lysvand H; Slupphaug G
Clin Immunol; 2017 Jan; 174():10-17. PubMed ID: 27871892
[TBL] [Abstract][Full Text] [Related]
4. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by cyclosporin A.
Dalaker M; Jacobsen T; Lysvand H; Iversen OJ
Acta Derm Venereol; 1999 Jul; 79(4):281-4. PubMed ID: 10429984
[TBL] [Abstract][Full Text] [Related]
5. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by traditional Chinese medicine.
Song P; Lysvand H; Yuhe Y; Liu W; Iversen OJ
J Ethnopharmacol; 2010 Jan; 127(1):171-4. PubMed ID: 19781613
[TBL] [Abstract][Full Text] [Related]
6. The psoriasis-associated antigen, pso p27, participates in the formation of complement activating immune-complexes in psoriatic scale.
Asbakk K; Bergh K; Iversen OJ
APMIS; 1990 Feb; 98(2):143-9. PubMed ID: 2302350
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of antibodies against the psoriasis-associated antigen pso p27 in cerebrospinal fluid from patients with low back pain and sciatica.
Zwart JA; Iversen OJ; Sand T; Dale LG; Unsgård G
Spine (Phila Pa 1976); 1999 Feb; 24(4):373-7. PubMed ID: 10065522
[TBL] [Abstract][Full Text] [Related]
8. The autoantigen Pso p27: a post-translational modification of SCCA molecules.
Iversen OJ; Lysvand H; Hagen L
Autoimmunity; 2011 May; 44(3):229-34. PubMed ID: 21231892
[TBL] [Abstract][Full Text] [Related]
9. Detection of psoriasis-associated antigen pso p27 in sarcoidosis bronchoalveolar lavage fluid using monoclonal antibodies.
Jacobsen T; Lie BA; Lysvand H; Wiig M; Pettersen HB; Iversen OJ
Clin Immunol Immunopathol; 1996 Oct; 81(1):82-7. PubMed ID: 8808646
[TBL] [Abstract][Full Text] [Related]
10. An antigenic determinant is shared by psoriasis-associated p27 antigen and the Fc part of human IgG.
Asbakk K; Rødahl E; Lysvand H; Iversen OJ
APMIS; 1991 Jun; 99(6):551-6. PubMed ID: 1711328
[TBL] [Abstract][Full Text] [Related]
11. Participation of antigens related to the psoriasis associated antigen, pso p27, in immune complex formation in patients with ankylosing spondylitis.
Rødahl E; Asbakk K; Iversen OJ
Ann Rheum Dis; 1988 Aug; 47(8):628-33. PubMed ID: 3415362
[TBL] [Abstract][Full Text] [Related]
12. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis.
Henno A; Blacher S; Lambert CA; Deroanne C; Noël A; Lapière C; de la Brassinne M; Nusgens BV; Colige A
J Dermatol Sci; 2010 Mar; 57(3):162-9. PubMed ID: 20071151
[TBL] [Abstract][Full Text] [Related]
13. The expression of retrovirus-like particles in psoriasis.
Iversen OJ
J Invest Dermatol; 1990 Nov; 95(5 Suppl):41S-43S. PubMed ID: 16788630
[TBL] [Abstract][Full Text] [Related]
14. Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress.
Chimenti MS; Sunzini F; Fiorucci L; Botti E; Fonti GL; Conigliaro P; Triggianese P; Costa L; Caso F; Giunta A; Esposito M; Bianchi L; Santucci R; Perricone R
Front Immunol; 2018; 9():2363. PubMed ID: 30429845
[TBL] [Abstract][Full Text] [Related]
15. Use of scale antibodies for the detection of antigens in psoriatic lesions.
Iversen OJ; Bergh K; Lysvand H
Acta Derm Venereol; 1993 Feb; 73(1):31-4. PubMed ID: 8095747
[TBL] [Abstract][Full Text] [Related]
16. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
Henri P; Prevel C; Pellerano M; Lacotte J; Stoebner PE; Morris MC; Meunier L
Br J Dermatol; 2020 Mar; 182(3):678-689. PubMed ID: 31145809
[TBL] [Abstract][Full Text] [Related]
17. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
Novelli L; Chimenti MS; Chiricozzi A; Perricone R
Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
[TBL] [Abstract][Full Text] [Related]
18. The psoriasis-associated antigen, pso p27, is expressed by tryptase-positive cells in psoriatic lesions.
Iversen OJ; Lysvand H; Jacobsen T; Bergh K; Lie BA
Arch Dermatol Res; 1995; 287(5):503-5. PubMed ID: 7625863
[No Abstract] [Full Text] [Related]
19. Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.
Visser MJE; Tarr G; Pretorius E
Front Immunol; 2021; 12():688861. PubMed ID: 34335591
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity.
Ruffilli I; Ragusa F; Benvenga S; Vita R; Antonelli A; Fallahi P; Ferrari SM
Front Endocrinol (Lausanne); 2017; 8():139. PubMed ID: 28674524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
